Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary tract infections

C D Bacheller1, J M Bernstein

  • 1Division of Infectious Diseases, Wright State University School of Medicine, Dayton, Ohio, USA.

The Medical Clinics of North America
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Glanders.

The Hospital·2018
Same author

Rhabdomyosarcoma of the trachea: first reported case treated with proton beam therapy.

The Journal of laryngology and otology·2012
Same author

Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Same author

Unilateral transverse cordotomy for bilateral abductor vocal fold immobility.

The Journal of laryngology and otology·2012
Same author

Observations ON HUMAN GLANDERS: WITH A STUDY OF SIX CASES AND A DISCUSSION OF THE METHODS OF DIAGNOSIS.

British medical journal·2010
Same author

Remarks ON INFECTION BY B. COLI IN THE PUERPERIUM, AND ON THE INFECTIVE CONDITIONS OF PREGNANCY.

British medical journal·2010
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Urinary tract infections (UTIs) remain a significant health burden, with E. coli as the primary cause. However, rising antibiotic resistance is altering effective treatment strategies for these common infections.

Area of Science:

  • Urology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Urinary tract infections (UTIs) cause 7 million annual patient visits and exceed $1 billion in costs.
  • Diagnostic methods like dipstick cultures offer rapid pathogen identification.
  • Empiric therapy is often more cost-effective than cultures for uncomplicated UTIs in women.

Purpose of the Study:

  • To review the current landscape of UTI etiology and antibiotic susceptibility.
  • To highlight changes in resistance patterns impacting treatment efficacy.

Main Methods:

  • Review of epidemiological data on UTI causes.
  • Analysis of antibiotic susceptibility trends over two decades.
  • Evaluation of diagnostic and therapeutic approaches.

Related Experiment Videos

Main Results:

  • Escherichia coli remains the predominant UTI pathogen.
  • Significant shifts in antibiotic susceptibility patterns are observed.
  • Ampicillin utility has decreased due to resistance.
  • Reduced susceptibility to quinolones is noted for gram-negative pathogens.
  • Emergence of resistant organisms like Pseudomonas and Enterococcus faecium requires monitoring.

Conclusions:

  • While UTI etiology is stable, antibiotic resistance patterns are evolving rapidly.
  • Treatment strategies must adapt to changing susceptibility profiles.
  • Vigilance against emerging resistant organisms is crucial for effective UTI management.